Halliburton fourth-quarter profit beats, firm takes charge for Venezuela
January 22, 2018S&P, Nasdaq drift higher ahead of Senate vote on funding
January 22, 2018Biotech M&A takes off as Sanofi and Celgene spend $20 billion
at
(Reuters) – Biotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add new products for hemophilia and cancer to their medicine cabinets.
Powered by WPeMatico
